Skip to content

Case study

AI-powered platform automating clinical site evaluation for faster, compliant trial startups

The solution leverages AI agents to automate sequential clinical site evaluation, with validated handoffs between feasibility and pre-activation stages so that only qualified sites advance to contracting and activation.

3 min readArtificial IntelligenceHealthcareAI and Machine Learning

Key result40% faster clinical trial launches
AI and Machine Learning
Industry
Healthcare & Life Sciences
Category
Artificial Intelligence
Engagement
AI-Driven Site Feasibility & Qualification Platform
Users
Sponsors, CROs & Clinical Research Associates (CRAs)

Results at a glance

  1. 0140% faster clinical trial launches

    Automated, protocol-aligned site evaluation and structured CRA qualification shortened the path from feasibility to trial activation.

  2. 0230% reduction in site selection cycle time

    AI-assisted scoring, shortlisting, and sequential agent handoffs reduced the time needed to identify and qualify suitable sites.

  3. 03Higher Selection Accuracy

    AI-driven automation improves accuracy and consistency in site evaluation, reducing the risk of subjective or error-prone decisions.

01The client

Customer

The client operates in the Clinical Research and Life Sciences space, supporting sponsor- and CRO-oriented clinical trial operations.

Trial timelines were routinely delayed by poor site selection, missing documents, staffing gaps, and regulatory issues, resulting in delayed FPFV, higher costs, protocol deviations, and heavy manual coordination overhead.

Site evaluation relied on traditional, manual workflows (manual reviews, email questionnaires, and subjective scoring) rather than a standardized, data-driven process.

02Challenge

Business Challenge

As trial volumes grew, the client's clinical operations team faced a set of operational and compliance challenges that made site selection slow, inconsistent, and difficult to audit:

  1. 01Inconsistent Site Scoring

    Site evaluations relied on subjective, manual reviews rather than standardized, protocol-aligned criteria.

  2. 02Limited Historical Insight

    Feasibility decisions lacked access to historical site performance data, making comparisons across sites unreliable.

  3. 03Manual Document Verification

    Verifying site documentation by hand slowed reviews and left the process with poor audit readiness.

  4. 04Fragmented CRA Qualification

    CRA-led site qualification processes were fragmented, lacking digital standardization or integration into activation pipelines.

  5. 05Undetected Early Risks

    Inefficient feasibility evaluations produced slow, inconsistent decisions and let operational and compliance risks go undetected until later stages.

  6. 06Delayed Trial Startups

    Poor site selection, missing documents, staffing gaps, and regulatory issues delayed FPFV, increased costs, and caused protocol deviations.

03Solution

Solution

The solution leverages AI agents to automate sequential clinical site evaluation, with validated handoffs between feasibility and pre-activation stages so that only qualified sites advance to contracting and activation.

Feasibility Agent

Assesses site suitability against protocol requirements and historical performance data to generate AI-assisted site shortlisting.

Pre-Activation Agent

Verifies operational readiness, confirming documents, staffing, and compliance checks are complete before a site can proceed.

Sequential AI Workflows

Validated handoffs between feasibility and pre-activation stages eliminate subjective site selection and detect risks early.

Structured CRA Qualification

Enforces structured, CRA-led site qualification, digitizing what was previously a manual, fragmented process.

Compliance & Audit Trails

Generates inspection-ready audit trails and secure compliance workflows throughout the evaluation process.

Configurable AI Scoring

Protocol-driven automation and configurable AI scoring, with mandatory CRA validation built into every decision.

04How we delivered

Implementation

The clinical site evaluation process was implemented as a sequential, agent-driven workflow that moves each site from initial protocol input to an activation-ready decision.

  1. Step 1Protocol Input

    Trial protocol requirements are fed into the platform as the starting point for site evaluation.

  2. Step 2Feasibility Assessment

    The Feasibility Agent performs scraping, scoring, questionnaire processing, and validation to shortlist suitable sites based on protocol requirements and historical data.

  3. Step 3Pre-Activation Verification

    Shortlisted sites move to the Pre-Activation Agent, which handles CRA onboarding, SQV (Site Qualification Visit) checklists, document validation, and scheduling.

  4. Step 4AI-Driven Qualification

    The Pre-Activation Agent applies AI-driven qualification checks, confirming staffing, documentation, and compliance are complete.

  5. Step 5Activation Readiness

    Only sites that pass both stages are marked activation-ready, with a structured, inspection-ready audit trail generated at each step.

05Technology

Technology

Backend Framework
FastAPIPython 3.10+
Workflow Orchestration
LangGraph for event-drivenagent-based workflow management
Data Storage
PostgreSQL
Automation & Scraping
Selenium for site data scraping
Security & Access
JWT-based Role-Based Access Control (RBAC)
Deployment
Docker containers for scalability and maintainability

06Results

The AI-driven site evaluation platform delivered measurable improvements in trial startup speed and site selection efficiency.

  • 40% faster clinical trial launches

    Automated, protocol-aligned site evaluation and structured CRA qualification shortened the path from feasibility to trial activation.

  • 30% reduction in site selection cycle time

    AI-assisted scoring, shortlisting, and sequential agent handoffs reduced the time needed to identify and qualify suitable sites.

07Business impact

Beyond faster site evaluation, the platform gives the client a more consistent, audit-ready, and scalable approach to clinical trial startups.

Higher Selection Accuracy

AI-driven automation improves accuracy and consistency in site evaluation, reducing the risk of subjective or error-prone decisions.

Fewer Manual Errors

Structured workflows and sequential agent handoffs reduce manual errors and keep the client audit- and compliance-ready.

Earlier Risk Detection

Early detection of operational and regulatory risks helps the client avoid delays and costly site failures before they happen.

Balanced Automation & Oversight

Integrating mandatory CRA validation with AI insights lets the client scale automation without losing human oversight.

Stronger Audit Readiness

End-to-end, inspection-ready audit trails strengthen regulatory preparedness and traceability across every site decision.

Fewer Activation Failures

Reduced site activation failures and improved operational efficiency support more reliable trial startups going forward.

More projects like this

All case studies

Facing a similar challenge?

Tell us what you need. A technical lead will reply within one business day with how we would approach it.

  • Reply within one business day
  • Free 30-minute call
  • NDA before you share data